Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries.
Getaneh AM, Li X, Mao Z, Johannesen CK, Barbieri E, van Summeren J, Wang X, Tong S, Baraldi E, Phijffer E, Rizzo C, van Wijhe M, Heikkinen T, Bont L, Willem L, Jit M, Beutels P, Bilcke J; for Respiratory Syncytial Virus Consortium in Europe (RESCEU) investigators. Getaneh AM, et al. Among authors: barbieri e. Vaccine. 2023 Feb 24;41(9):1623-1631. doi: 10.1016/j.vaccine.2023.01.058. Epub 2023 Feb 1. Vaccine. 2023. PMID: 36737318
COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works.
Gastaldi A, Donà D, Barbieri E, Giaquinto C, Bont LJ, Baraldi E. Gastaldi A, et al. Among authors: barbieri e. Children (Basel). 2021 Dec 6;8(12):1144. doi: 10.3390/children8121144. Children (Basel). 2021. PMID: 34943339 Free PMC article. Review.
A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis.
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. Reeves RM, et al. Among authors: barbieri e. J Infect Dis. 2022 Aug 12;226(Suppl 1):S110-S116. doi: 10.1093/infdis/jiac059. J Infect Dis. 2022. PMID: 35333332
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.
Willame C, Dodd C, Durán CE, Elbers R, Gini R, Bartolini C, Paoletti O, Wang L, Ehrenstein V, Kahlert J, Haug U, Schink T, Diez-Domingo J, Mira-Iglesias A, Carreras JJ, Vergara-Hernández C, Giaquinto C, Barbieri E, Stona L, Huerta C, Martín-Pérez M, García-Poza P, de Burgos A, Martínez-González M, Bryant V, Villalobos F, Pallejà-Millán M, Aragón M, Carreras JJ, Souverein P, Thurin NH, Weibel D, Klungel OH, Sturkenboom M. Willame C, et al. Among authors: barbieri e. Vaccine. 2023 Jan 4;41(1):251-262. doi: 10.1016/j.vaccine.2022.11.031. Epub 2022 Nov 22. Vaccine. 2023. PMID: 36446653 Free PMC article.
686 results